Neonc Technologies (NASDAQ:NTHI) President Amir Heshmatpour Buys 10,000 Shares of Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) President Amir Heshmatpour acquired 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 8th. The shares were acquired at an average price of $5.61 per share, with a total value of $56,100.00. Following the completion of the transaction, the president owned 3,027,000 shares in the company, valued at $16,981,470. The trade was a 0.33% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Neonc Technologies Stock Down 4.7%

NASDAQ:NTHI opened at $5.12 on Friday. Neonc Technologies Holdings, Inc. has a twelve month low of $3.20 and a twelve month high of $12.99. The stock’s 50-day simple moving average is $8.64 and its 200 day simple moving average is $9.12.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. Zacks Research raised shares of Neonc Technologies to a “hold” rating in a report on Wednesday, January 14th. Weiss Ratings reissued a “sell (e+)” rating on shares of Neonc Technologies in a research note on Friday, March 27th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Neonc Technologies presently has an average rating of “Reduce”.

Institutional Investors Weigh In On Neonc Technologies

Several hedge funds have recently modified their holdings of NTHI. Barclays PLC increased its holdings in Neonc Technologies by 5,314.8% in the fourth quarter. Barclays PLC now owns 9,151 shares of the company’s stock valued at $76,000 after purchasing an additional 8,982 shares during the period. Foundations Investment Advisors LLC acquired a new stake in Neonc Technologies in the third quarter valued at $100,000. SLT Holdings LLC acquired a new position in Neonc Technologies during the 3rd quarter worth about $100,000. Goldman Sachs Group Inc. acquired a new position in Neonc Technologies during the 4th quarter worth about $124,000. Finally, OMERS ADMINISTRATION Corp acquired a new position in Neonc Technologies during the 4th quarter worth about $126,000.

About Neonc Technologies

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.